Daria Filipowicz-Galas
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.
Journal: Cancer cell
Published: July 23, 2025
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.
Journal: Nature communications
Published: June 22, 2025
Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity.
Journal: Frontiers in oncology
Published: March 01, 2024
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2023
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.
Journal: Cytometry. Part B, Clinical cytometry
Published: April 18, 2022
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Journal: Frontiers in immunology
Published: October 17, 2020
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 23, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026